---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-145220"
form_type: "8-K"
ticker: "CHRS"
cik: "0001512762"
company_name: "Coherus Oncology, Inc."
filed_at: "2023-05-15T23:59:59+00:00"
generated_at: "2026-06-15T01:04:37.667559+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Coherus reduces ATM equity offering capacity from $150M to $63.75M

## Summary
- Aggregate offering price under ATM with Cowen reduced by $86.25M, from $150M to $63.75M.
- Amendment No. 1 to November 2022 Sales Agreement executed on May 15, 2023.
- Remaining capacity of $63.75M remains available for future at-the-market sales.

## SEC filing metadata
- accession: 0001193125-23-145220
- form_type: 8-K
- ticker: CHRS
- cik: 0001512762
- company_name: Coherus Oncology, Inc.
- filed_at: 2023-05-15T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 1.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1512762/000119312523145220/0001193125-23-145220-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1512762/000119312523145220/d443156d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-145220
- JSON: https://secwatch.observer/filing/0001193125-23-145220.json
- Plain text: https://secwatch.observer/filing/0001193125-23-145220.txt

## Key facts
- Material Agreements
  Coherus Oncology, Inc. amended Amendment No. 1 to Sales Agreement with Cowen and Company, LLC valued at $86.25 million (effective 2023-05-15).
  - Action: amendment
  - Agreement: atm program
  - Counterparty: Cowen and Company, LLC
  - Value: $86.25 million
  - Effective: 2023-05-15
  source text: reduced the amount of shares that could be issued and sold pursuant to its “at-the-market” program (“ATM”) with Cowen and Company, LLC (“Cowen”) in an amount equal to $86.25 million.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1512762/000119312523145220/0001193125-23-145220-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.